Study Information
Locations
Not Specified
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
The purpose of this study is to evaluate and rank-order generic substitution rates by therapeutic class, as well as examine factors associated with higher or lower rates of generic substitution.
PI is Jodi B. Segal, MD, MPH, Johns Hopkins School of Medicine.
PI is Jodi B. Segal, MD, MPH, Johns Hopkins School of Medicine.
Principal Investigator
External PI, Principal Investigator
Funder
U.S. Food and Drug Administration
Related Studies
Antimicrobial Resistant E. coli Before and After California Senate Bill 27 (ARES): A Natural Experiment
Natural experiment: test hypothesis that reductions in antimicrobial drug use in livestock production will be related to reductions in AMR in chicken meat, UTIs